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During the past several years, an investigation has been made of the rela-
tionships between various hormones of the adrenal cortex, the enzyme hya-
luronidase, and its substrate hyaluronic acid, with specific reference to tissue
permeability and collagen diseases. As the studies progressed, several prob-
lems were investigated: (i) which fractions of the adrenal cortex were
responsible for the results obtained, (ii) what mechanism or mechanisms
of action were involved, (iii) in what way the placenta, as well as the pitui-
tary gland, was involved in hyaluronic acid metabolism in relation to con-
nective tissue disease processes. In other studies, experimental evidence
has suggested an action of these adrenal hormones on the enzyme hya-
luronidase in vitro," while desoxycorticosterone, growth hormone, and the
related sex steroids, are without hyaluronidase-inhibitory effect.
Adrenocorticotrophic hormone was demonstrated to be a potent inhibitor
of the hyaluronidase-enhanced spreading phenomenon through the release
of the effective C-il adrenal steroids in the intact rabbit, rat, guinea pig,
mouse, and dog.'"
In view of the favorable influence of pregnancy on certain of the collagen
diseases, it was of interest to demonstrate that chorionic gonadotrophin ob-
tained from human pregnancy urine exhibited marked hyaluronidase-inhibi-
tory activity in normal, castrate, and hypophysectomized animals of both
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sexes in the presence of the adrenals, but was entirely without effect in
adrenalectomized animals. This inhibition also was produced by chorionic
gonadotropin preparations that had been heat inactivated to destroy gonado-
trophic activity, indicating that the effect was not due to the gonad-stimu-
lating principle but to a fraction that exhibited many of the properties pre-
viously associated with ACTH from the pituitary tissue.'2
These experimental findings led to investigations of placental tissue to
ascertain whether the source of the ACTH activity was the placenta itself
rather than the pituitary. Preliminary investigations of placental extracts,
using inhibition of exogenously added hyaluronidase as an index of adrenal
activity, indicated that significant quantities of ACTH are produced by
the human placenta although the crude methods of isolation employed did
not permit quantitative interpretations of yields or of purity. The hya-
luronidase-inhibitory effects produced by the various placental fractions
were markedly similar to those produced by the heat-inactivated human
chorionic gonadotropin preparations. It seemed, therefore, quite appropri-
ate to speak of placental ACTH as a substance that causes the adrenal to
produce a factor or factors that inhibit hyaluronidase, but not necessarily
to assume placental ACTH to have physiological characteristics identical
with those of pituitary ACTH.
That the placenta influences in some way the excretion of certain urinary
steroids may be presumed from the work of Venning and Browne'8 who
noted the increase of urinary corticoids in the last trimester of pregnancy.
It was, therefore, of interest to establish whether a urinary steroid pattern
similar to that observed following administration of pituitary ACTH would
result from administration of placental ACTH to normal and hypophysec-
tomized animals. Forsham et al.5 have shown that pituitary ACTH causes
significant rises in the excretion of both corticoids and 17-ketosteroids in
man. Burstein' observed a rise of 400 per cent in the excretion of corticoids
in guinea pigs, after the injection of 1 mg. of pituitary ACTH per animal.
An increase of excretion of 17-ketosteroids in guinea pigs treated with
ACTH was reported by Clayton and Prunty.8 The increased excretion of
17-ketosteroids in normal and hypophysectomized rats after injection of
ACTH was noted by Kowaleski.8 We have studied the influence of crude
placental ACTH fractions on the excretion of urinary corticoids and 17-
ketosteroids in guinea pigs and in rabbits. Results from investigations point
out that the measurement of urinary steroid excretion in guinea pigs is a
reliable method for the evaluation of ACTH activity in placental tissues,
and that this method may be used as a further assay procedure.
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MATERIALS AND METHODS
It has been experimentally established that the choice of suitable animals for the
study of urinary steroids is of some importance.* Burstein' demonstrated that guinea
pigs are sensitive and reliable animals for the determination of urinary corticoids, and
Clayton and Prunty8 have reported comparable results from their studies of urinary
17-ketosteroid excretions in guinea pigs.
Forty-two male guinea pigs from our own colony, fed on commercial rabbit pellets
and water ad libitum, were employed. The weights of animals ranged from 425 to
675 grams. During the experimental period, and for 10 days preceding the collection
of urines, no carrots nor other colored vegetables were given. Urines were collected
over a 17-hour period from fasting animals kept in separate metabolic cages, as sug-
gested by Burstein.2 Animals were fed and received water during a 7-hour interval
when the collection of urines was discontinued. The injection of test substances was
done immediately before placing the animals in the cages for urine collections.
Acidified-acetone preparations of crude placental ACTH prepared by our modifica-
tion of the Lyon's procedure for the extraction of mammotropic hormone, previously
described in detail,14 were used in these experiments. These preparations were dissolved
in sterile 0.9 per cent saline (10 mg. per cc.) and were injected intraperitoneally or
subcutaneously in amounts of 20 mg. per kilogram of body weight.
Three control series of animals were employed in these studies. One group received
pituitary ACTH (Nordic Biochemicals Ltd.) in doses of 2 mg. per kilogram of body
weight. Another group was treated with an extract of liver tissue prepared by the
same procedure and given in the same doses as the placental ACTH fractions. The
third group received saline in amounts of 2 ml. per kilogram of body weight. In all
cases, 2 ml. of solution per kilogram of body weight of animals were given.
The phosphomolybdic acid method, as described by Heard and Sobel,' was used for
the determination of corticoids. Phosphomolybdic acid was prepared, omitting the
tungstic acid as suggested by Burstein,2 and the extraction and evaporation of extracts
was carried out. As shown from the study of corticoids in human urine by Romanoff'5
and from published experimental results by Burstein on corticoid excretion in guinea
pigs, the phosphomolybdic method permits the evalution of ACTH activity with the
same precision as does the formaldehydrogenic method.
The 17-ketosteroids were determined with the modification of classic techniques as
described by Masuda and Thuline.9 In this modification, the Zimmermann color is
extracted with amylacetate which leaves behind, in the aqueous layer, the nonketonic
interfering chromogens, as was proved by the micro-Girard separation and chromatog-
raphy.
Only male guinea pigs were used in these studies. As noted by Zondek and
Burstein,'9 there is a cyclical variation of both corticoids and 17-ketosteroids in the
urine. These results were also noted in women by Venning and Kazmin.'7 We
therefore used male animals, in which existing daily variations are acyclical.
* Guinea pigs have the largest adrenal-weight/body-weight ratio among animals
thus far studied; the ratio being 0.1 for guinea pigs, and 0.01 for adult man. This
difference would serve to explain why values for urinary steroids are relatively high
in guinea pigs.
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The methods and precautions as to general procedures, and test substances studied,
as well as the extraction procedures employed, have been described in detail in our
earlier publications.
EXPERIMENTAL RESULTS
The noted daily variations of resting values of the excretion of both corti-
coids and 17-ketosteroids in guinea pigs are in accord with the results of
TABLE 1. INFLUENCE OF PLACENTAL AND PITUITARY ACTH ON THE URINARY
EXCRETION OF CORTICOIDS (MICROGRAMs/17 HRS.) IN MALE GUINEA PIGS
Placen- Pitui-
tal tary
Treatment: None ACTH None ACTH None
Days: 1 2 3 4 5 6 7 8 9 10
B.W.
Animals Gm.
1 425 231 181 160 242 668 231 184 506 268 277
2 560 121 210 200 206 744 276 252 521 329 300
3 600 161 210 181 184 878 259 230 667 147 182
4 650 131 260 260 224 878 182 200 582 276 277
5 560 128 130 230 247 705 182 182 490 256 240
6 650 231 130 230 247 520 188 190 537 153 166
Days: 1 2 3 4 5 6 7 8 9 10 11
7 490 170 181 173 187 500 216 238 646 542 168 193
8 495 200 218 200 178 528 246 266 868 694 271 207
9 530 219 140 182 200 544 266 268 640 604 174 201
10 588 282 208 173 196 652 184 246 668 656 295 220
11 605 229 256 191 178 636 192 206 650 674 271 297
12 612 200 236 182 212 652 274 160 620 638 300 242
Dosage: Placental ACTH: 20 mg. (2 ml.)/Kg. B.W. intraperitoneally.
Pituitary ACTH: 2 mg. (2 ml.)/Kg. B.W. intraperitoneally in animals 1-6.
Pituitary ACTH: 2 mg. (2 ml.)/Kg. B.W. subcutaneously in animals 7-12.
Burstein' and of Clayton and Prunty8 who studied urinary steroid excretion
in animals, and of Kowaleski7 who presented comparable results from stud-
ies in man. This variability necessitated repeated determinations of steroid
excretion during stated time intervals preceding the administration of test
substances. The results of our experiments are presented in the following
tables:
Table 1 indicates the values of corticoid excretion in 12 guinea pigs before
and after the injection of placental and pituitary ACTH. Placental ACTH
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was injected intraperitoneally into all animals; pituitary ACTH was given
intraperitoneally to six guinea pigs, and subcutaneously to a second group
of six guinea pigs. Subcutaneous injection was made during the two 17-
hour periods. The range of resting basic values for 12 animals varied from
121 to 282 ,gm. The range of values following a single intraperitoneal in-
jection of placental ACTH, was from 500 to 878 ,ugm. The marked rise of
corticoid excretion following administration of placental ACTH was of
TABLE 2. URINARY EXCRETION OF CORTICOIDS (MICROGRAMs/17 HRS.) IN
MALE GuINEA PIGS AFTER INJECTION OF NORMAL SALINE
AND PLACENTAL ACTH
Treatment: None Saline None Placental ACTH None
Days: 1 2 3 4 5 6 7 8
B.W.
Animals Gm.
13 464 193 218 238 193 523 554 206 209
14 490 212 206 200 244 575 578 182 190
15 487 212 245 238 251 591 594 215 185
16 520 231 252 193 180 480 487 188 212
17 465 171 182 200 170 512 501 212 179
18 531 238 245 192 226 543 563 209 190
19 510 213 231 238 245 560 532 181 197
20 496 182 193 182 231 512 498 189 197
Dosage: Saline: 2 ml./kg. B.W. intraperitoneally.
Placental ACTH: 20 mg. (2 ml.)/kg. B.W. subcutaneously.
short duration and the following 17-hour period resulted in the return of
corticoid excretion to nearly resting values (ranging from 182 to 276 ,ugm).
Comparable results were observed after the injection of pituitary ACTH,
and no notable differences were obtained between the groups injected sub-
cutaneously or intraperitoneally.
Table 2 shows the results of intraperitoneal injection of saline (2 cc. per
kilogram of body weight) on the excretion of corticoids, and the effect of
placental ACTH injected subcutaneously on corticoid excretion. These
studies were made to exclude the possibility of non-specificity or trauma as
a factor in the results observed, since it has been pointed out by Forbes'
and by Talbot' that trauma may effect urinary steroid excretion. As may
be seen from the results of these studies, no notable influence was observed
following the injection of saline. Table 2 shows, also, that the subcutaneous
administration of placental ACTH provoked a definite rise in the excretion
s8
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of corticoids during the period of treatment. Comparison of data in Tables
1 and 2 would indicate that the intraperitoneal injection resulted in slightly
higher values than the subcutaneous one, but in both cases, the results of
adrenal trophic activity of placental ACTH were self-evident.
Table 3 represents the results of other control experiments. A liver ex-
tract was administered to 1 guinea pigs, intraperitoneally, in doses of 20
mg. per kilogram of body weight. Urinary corticoids were examined be-
TABLE 3. ExCRETION OF URINARY CORTICOIDS (MICROGRAMS/17 HRS.)
AFTER THE INJECTION OF LIVER EXTRACT
Treatment:
Days:
B.W.
Animals Gm.
21 644
22 650
23 700
24 702
25 720
26 750
27 770
28 772
29 780
30 895
None
Liver tissue
extract
1 2 3 4
120 173
146 132
205 261
194 170
230 210
219 192
241 210
214 272
277 280
261 310
148
174
246
234
225
240
270
280
245
267
5
None
6 7
210 230 211 183
160 205 194 172
252 245 250 260
242 260 243 231
240 190 232 194
203 244 218 188
242 261 254 236
264 282 270 244
286 255 250 271
292 259 248 258
Dosage: 20 mg. (2 ml.)/kg. W.W. intraperitoneally.
fore, during and after treatment. No significant
excretion were noted as a result of this treatment.
differences in corticoid
Table 4 presents the values of 17-ketosteroid excretion in guinea pigs
when placental ACTH was injected intraperitoneally, and pituitary ACTH
was injected subcutaneously. The range of basic vales for 12 animals ex-
amined during the two 17-hour periods prior to treatment was from 200
to 300 pgm (24 determinations). The placental ACTH, injected the third
day, resulted in a definite rise in the excretion of 17-ketosteroids, the range
of values after treatment being from 615 to 928 ,gm. The injection of
pituitary ACTH also resulted in a definite increase of urinary 17-ketos-
teroid excretion in the animals treated`' during the 17-hour periods, and
when treatment was discontinued, the return to nearly basic values was
observed.
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Table 5 summarizes the results presented in Tables 1-4. Review of the
tables indicates that the results are statistically significant. There is no
overlapping of values of steroid excretion found before and after treatment
in the various groups of animals. High standard deviations noted in a few
groups of treated animals are due to the large range of values of steroids
found after the injection of tested substances.
TABLE 4. THE INFLUENCE OF PLACENTAL AND PITUITARY ACTH ON THE
URINARY EXCRETION Or 17-KETOSTEROIDS (MICRoGRAMs/17 HRS.)
IN MALE GUINEA PIGS
Treatment:
Days:
B.W.
Animals Gm.
31 540
32 490
33 496
34 580
35 690
36 675
37 610
*38 645
39 615
40 605
41 618
42 646
Placental
None
1 2
220
340
246
364
288
323
200
230
296
278
278.
242
283
262
282
316
309
268
312
312
234
234
296
270
ACTH
3
690
928
740
892
786
668
735
635
775
635
690
615
Pituitary
None ACTH
4 5 6 7
410
234
270
394
588
240
278
270
215
226
253
235
192
210
232
376
382
188
245
276
212
238
244
226
* . .
* . .
* . .
* . .
* . .
780
855
855
880
830
910
* . .
* . .
* . .
* . .
564
784
816
656
764
880
Dosage: Placental ACTH: 20 mg. (2 ml.)/Kg. B.W. intraperitoneally.
Pituitary ACTH: 2 mg. (2 ml.)/Kg. B.W. intraperitoneally.
DISCUSSION
The methods employed in the investigation of ACTH and adrenal steroid
activity have shown wide variation in qualitative and quantitative response
to materials of varied physiologic origin. This variation has also reflected
the state and method of purification or extraction, dosage regimen, and
route of administration. These data indicate that, despite daily variations
in urinary steroid excretion, such assays may serve as valid indices of
adrenal cortical activation. These data further tend to confirm material
presented in an earlier paper1' concerning the presence of ACTH in human
placental tissues and to indicate that measurements of urinary steroid ex-
cretion are reliable for the evaluation of placental ACTH activity and for
None
8 9
* . .
* . .
* . .
* . .
337
281
318
327
255
289
* . .
* . .
* . .
255
281
289
271
261
265
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confirming of purification procedures for this substance in addition to hya-
luronidase-inhibition studies hitherto performed.
The data depicted in Figure 1 demonstrate that crude placental ACTH,
extracted by acidified-acetone fractionation procedures,1' produces a marked
increase in urinary excretion of corticoids and 17-ketosteroids entirely
comparable with the results produced by the administration of pituitary
TABLE 5. AVERAGE VALUES, STANDARD DEVIATlONS, AND THE RANGES
OF EXCRETION OF URINARY STEROIDS IN MALE GUINEA PIGS;
SUMMARIZING RESULTS PRESENTED IN TABLES 1-4
Mode of injection
Intraperitoneally
Subcutaneously
Intraperitoneally
Intraperitoneally
No. of
animals
12
8
Corticoids, (micrograms/17 hrs.)
Day before Day after
injection: injection:
208 ± 25 (178-247)
217 ± 29 (170-251)
659 ± 123 (500-878)
537 ± 36 (480-591)
8 221 + 24 (182-252) 210 ± 19 (182-238)
10 243 ± 41 (148-280) 239 ± 38 (160-292)
Pituitary Intraperitoneally
ACTH Subcutaneously
6 204 + 26 (182-252)
6 230+37(160-268)
550 + 36 (490-667)
682 ± 84 (620-868)
Intraperitoneally
Intraperitoneally
17-Ketosteroids, (micrograms/17 hrs.)
12 281 ± 28 (234-316) 732 ± 95 (615-928)
6 270 + 34 (212-276) 851 ± 50 (780-910)
ACTH. This was found when the intraperitoneal or subcutaneous route
was employed. The injection of saline and liver extract is shown to pro-
duce no significant alteration ascribable to non-specificity or trauma.
While the assay of hormonal materials by inhibition of exogenously
added hyaluronidase in hyaluronidase-enhanced spreading (hypophysec-
tomized mice or rats) indicates that acetic acid-extracted pituitary and
placental ACTH have roughly the same order of activity, alteration of the
extraction procedure produces variation in results (Fig. 2) indicated as
diminution of the activity of purified materials.
When other assay techniques such as the mobilization of adrenal ascorbic
acid or eosinopenic response are employed in investigations of the activity
of placental or pituitary preparations, wide variations in activity are noted.
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Placental
ACTH
Saline
Liver tissue
extract
Placental
ACTH
Pituitary
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These variations may be dependent upon dosage administered, experimen-
tal animals employed, and routes or times of administration used in the
study of test preparations. In these assays, purification procedures induce
further variations reflected as increased activity of the purified materials.
The identity of results obtained when the urinary steriod excretion level
is employed as the assay procedure, despite the use of materials of varied
physiologic origin, or route of administration, recommends its employment
80
40
60
20
80
40
80
40
Plac. ACTH In pertt 12 Plac. ACTH S. Cut. 8 ao0 FN T Im m i
Saline In perit. 8 Liver Ex. In perit. 10
10 PIt. ACTH In perit. 6 Pit. ACTH S. Cut. 6
'0
17 KETOSTEROIDS - MICROGRAMS 17 H R S.
Plac. ACTH In 12 Pit. ACTH In 6
0: perit. perit.
OL Day before Injection
V
Day after injection
I tandard Mean values
FIG. 1. Comparison of placental and pituitary ACTH on excretion of urinary steroids
in male guinea pigs.
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as a further index of adrenal cortical activation and, in addition, confirms
our earlier work concerning the presence of ACTH in human placental
tissues.
EFFECT OF FRACTIONATION PROCEDURES
PITUITARY HUMAN PLACENTA
Acidified Acetic Oxycellulose
Acetone Acid Treatment
Extraction Extraction ofAcidified
AcetonePdr.
LA-IA
H~~~~~~~~~~~~--
1.0 35 1* 1** 1.05050
Fr Jl I
DOSAGE IN Mg.
505.0* 0.1 0.51.0
* Acetic Acid Extr
* *Oxycellulose Treat.
* * *Residue Froction
FIG. 2. Inhibition of hyaluronidase-enhanced spreading reaction in hypophysectomized
mice (placental and pituitary ACTH).
SUMMARY
1. Further confirmation of our earlier work concerning the production
of ACTH by the human placenta is presented.
2. The administration of crude placental ACTH results in a marked
increase in the urinary excretion of 11-oxycorticoids and 17-ketosteroids in
male guinea pigs.
3. Recent work from our laboratories has led to the conclusion that
stimulation of the adrenal cortex by ACTH of either pituitary or placental
origin results in a physiological mixture of hormones that is more effective
than would be predicted on the basis of individual components, or, in the
production of hyaluronidase-inhibitory hormones not thus far studied.
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4. Further suggested is the possibility that placental ACTH of human
origin may well be obtained for clinical usage.
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